Email this article Medicines in the rehabilitation of patients after myocardial infarction: angiotensin-converting enzyme inhibitors
- Authors: Galyavich A.S1
-
Affiliations:
- Kazan State Medical University
- Issue: Vol 1, No 1 (2010)
- Pages: 62-64
- Section: Articles
- URL: https://journals.rcsi.science/2221-7185/article/view/44968
- DOI: https://doi.org/10.26442/CS44968
- ID: 44968
Cite item
Full Text
Abstract
The paper analyzes the use of angiotensin-converting enzyme (ACE) inhibitors in patients after prior myocardial infarction. It presents the data of controlled studies, which indicate that it is warranted to use ACE inhibitors to improve prognosis in patients. It is concluded that it is unreasonable for a physician not to prescribe ACE inhibitors to post-myocardial infarction patients with obvious or asymptomatic left ventricular dysfunction and to diabetic patients (if no contraindications).
Full Text
##article.viewOnOriginalSite##About the authors
A. S Galyavich
Kazan State Medical Universityд-р мед. наук, проф., зав. каф. факультетской терапии
References
- Dargie H.J., Mc Alpine M, Morton J.J. Neuroendocrine activation in acute myocardial infarction. J Cardiovasc Pharmacol 1987; 9 (Suppl. 2): S21–4.
- Pfeffer J.M., Pfeffer M, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res 1985; 57: 84–95.
- Pfeffer M.A., Braunwald E.A., Moyé L.A. et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival And Ventricular Enlargement trial. N Engl J Med 1992; 327: 669–77.
- De Kam P.J., Voors A.A. et al. Effect of very early angiotensin - converting enzyme inhibition on left ventricular dilatation after myocardial infarction in patients receiving thrombolysis. J Am Coll Cardiol 2000; 36: 2047–53.
- Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. The prognostic value of predischarge quantitative two - dimensional echocardiographyc measurements and the effects of early lisinopril treatment on left ventricular structure and function after acute myocardial infarction in the GISSI-3 trial. Eur Heart J 1996; 17: 1646–56.
- Greenberg B, Quinones M.A. et al. Effects of long - term enalapril therapy on cardiac structure and function in patients with left netricular dysfunction. Results of the SOLVD Echocardiographic Study. Circulation 1995; 91: 2573–81.
- Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy. Lancet 1993; 342: 821–8.
- Kober L, Torp-Pedersen C, Carlsen J.E. et al. for the trandolapril cardiac evaluation (TRACE) study group: a clinical trial of the angiotensin converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995; 33: 1670–6.
- Kang P.M., Landau A.J., Eberhardt R.T., Frishman W.H. Angiotensin II receptor antagonists: a new approach to blockade of the renin - angiotensin system Am Heart J 1994; 127: 1388–401.
- Ferner R.E., Simpson J.M., Rawlins M.D. Effects of intradermal bradykininn after inhibition of angiotensin converting enzyme. Br Med J 1987; 294: 1119–20.
- Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. Eur Heart J 2004; 25: 1454–70.
- Mac Murray J, Cohen-Solal A, Dietz R et al. Practical recommendations for the use of ACE inhibitors, beta - blockers and spironolactone in heart failure: putting guidelines into practice. Eur J Heart Failure 2001; 3: 495–502.
